(Press-News.org) [Singapore, 10:05 a.m. SGT--September 12, 2023] - Intensity-modulated radiation therapy, or IMRT, should be utilized for locally advanced NSCLC to reduce the risk of severe pulmonary toxicity and radiation exposure to the heart, according to research presented today at the International Association for the Study of Lung Cancer 2023 World Conference on Lung Cancer in Singapore.
Dr. Stephen Chun, MD Anderson in Houston, Texas, presented a comprehensive analysis of the phase III trial NRG Oncology-RTOG 0617, comparing intensity-modulated radiation therapy (IMRT) with 3D-conformal radiotherapy (3D-CRT) for long-term outcomes in NSCLC patients.
Concurrent photon-based chemoradiation is an established standard of care for unresectable locally advanced non-small cell lung cancer (NSCLC), However, the choice between IMRT and 3D-CRT has remained contentious due to limited prospective data. As IMRT is more labor-intensive and costlier than 3D-CRT, it is important to justify IMRT utilization based on long-term prospective outcomes.
The secondary analysis of NRG Oncology-RTOG 0617, spanning a median follow-up of 5.2 years, involved 482 patients with locally advanced NSCLC. Among them, 47% received IMRT and 53% received 3D-CRT. The study examined a range of parameters including 5-year overall survival (OS), progression-free survival (PFS), time to local failure (LF), distant metastasis-free survival (DMFS), adverse events, and the development of second malignancies.
Dr. Chun's findings revealed that both IMRT and 3D-CRT groups exhibited similar OS, PFS, time to LF, and DMFS rates at the 5-year mark. Notably, IMRT was associated with a more than two-fold reduction in severe pneumonitis (3.5% vs. 8.2%) compared to 3D-CRT, demonstrating a clear advantage in reducing pulmonary toxicity.
Further analysis indicated a continuous association between heart V20-60Gy and survival, with heart V40Gy < 20% linked to significantly improved survival rates. Multivariable analysis underscored the significance of heart V40Gy ≥ 20% in predicting worse survival. In contrast, lung V5Gy did not significantly impact survival. Rates of second malignancy development were similar between IMRT and 3D-CRT groups.
Dr. Chun concluded that IMRT should be the preferred choice for locally-advanced NSCLC to mitigate severe pulmonary toxicity and minimize radiation exposure to the heart. The study emphasized the importance of optimizing radiation planning, with special attention to reducing lung V20Gy and heart V20-60Gy, aiming for a heart V40Gy < 20%. Encouragingly, the study did not find evidence that the low-dose bath (lung V5Gy) had a substantial impact on long-term survival or late severe toxicity.
These findings provide a crucial contribution to the ongoing discourse on radiation techniques for NSCLC treatment, paving the way for more informed clinical decisions and improved patient outcomes, according to Dr. Chun.
The study was supported by Eli Lily and Company and grants from the National Cancer Institute R50CA275822, U10CA180868, and U10CA180822.
About the IASLC:
The International Association for the Study of Lung Cancer (IASLC) is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 8,000 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis, and treatment of all thoracic malignancies. Visit http://www.iaslc.org for more information.
About the WCLC:
The WCLC is the world’s largest meeting dedicated to lung cancer and other thoracic malignancies, attracting more than 7,000 researchers, physicians, and specialists from more than 100 countries. The goal is to increase awareness, collaboration, and understanding of lung cancer, and to help participants implement the latest developments across the globe. The conference will cover a wide range of disciplines and unveil several research studies and clinical trial results. For more information, visit https://wclc2023.iaslc.org
END
Long-term outcomes of radiation techniques for locally advanced non-small cell lung cancer presented at IASLC 2023 Conference in Singapore
2023-09-12
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Reproductive factors associated with higher risk of lung cancer in women
2023-09-12
[Singapore, 10:05 a.m. SGT--September 12, 2023] - A study presented at the International Association for the Study of Lung Cancer 2023 World Conference on Lung Cancer revealed that key reproductive factors such as early menopause, shortened reproductive span, and early age at first birth are associated with elevated risks of lung cancer in women.
Researchers from Xiangya Hospital, Changsha, Hunan, China, conducted a prospective cohort study involving 273,190 participants from the UK Biobank to delve into the links between individual reproductive ...
Dark matter halos measured around ancient quasars
2023-09-12
At the center of every galaxy is a supermassive black hole. Beyond a certain size, these become active, emitting huge amounts of radiation, and are then called quasars. It is thought these are activated by the presence of massive dark matter halos (DMH) surrounding the galaxy, directing matter towards the center, feeding the black hole. A team including researchers from the University of Tokyo have, for the first time, surveyed hundreds of ancient quasars and found this behavior is very consistent throughout history. This is surprising, as many large-scale processes show variation throughout the ...
Arf1 inhibitors promote the infiltration of cytotoxic T lymphocytes into tumors by affecting lipid metabolism
2023-09-12
In recent years, cancer immunotherapies, represented by immune checkpoint blockade (ICB), have been highly successful and have become an important basis for the future treatment of cancers. However, the absence of tumoral killer T cells and the complexity of tumor microenvironment can both affect the immunotherapeutic efficacy. Therefore, it is urgent to develop novel anti-tumor agents that can effectively promote effector T cell infiltration in tumors.
ADP-ribosylation factor 1 (Arf1) is a member of the Ras small GTPase family and is ...
Intensity-modulated radiation therapy provides long-term benefits to patients with locally advanced lung cancer
2023-09-12
Intensity-modulated radiation therapy (IMRT) should be the preferred choice when treating patients with locally advanced non-small cell lung cancer (NSCLC), as it reduces radiation exposure to the heart and lungs, according to researchers at The University of Texas MD Anderson Cancer Center.
Results from a long-term secondary analysis of the NRG Oncology-RTOG 0617 Phase III study, with a median follow-up of 5.2 years, revealed that patients receiving IMRT had a more than two-fold reduction in severe lung inflammation (pneumonitis) compared to those who received 3D-conformal radiotherapy ...
New super-fast flood model has potentially life-saving benefits
2023-09-12
Published in Nature Water, the new model has major potential benefits for emergency responses, reducing flood forecasting time from hours and days to just seconds, and enabling flood behaviour to be accurately predicted at super-fast speeds as an emergency unfolds.
University of Melbourne PHD student Niels Fraehr, alongside Professor Q J Wang, Dr Wenyan Wu and Professor Rory Nathan, from the Faculty of Engineering and Information Technology, developed the Low-Fidelity, Spatial Analysis ...
In maize, co-expression of GAT and GR79-EPSPS provides high glyphosate resistance, along with low glyphosate residues
2023-09-12
This study is led by Dr Zhihong Lang (Biotechnology Research Institute, Chinese Academy of Agricultural Sciences). To develop a new bio-breeding resource for glyphosate-resistant maize, a large transgenic maize population was generated with introducing a codon-optimized glyphosate N-acetyltransferase gene, gat, and the enolpyruvyl-shikimate-3-phosphate synthase gene, gr79-epsps, into maize and a transgenic event, designated GG2, was highly resistant to glyphosate in consecutive generations of glyphosate screening. “This result is very encouraging.” Dr Lang says.
The ...
IOP Publishing and the Japan Society of Applied Physics convert Applied Physics Express to fully gold OA
2023-09-12
IOP Publishing (IOPP) and the Japan Society of Applied Physics (JSAP) announce that Applied Physics Express (APEX) is to become fully open access (OA). From January 2024, all articles published in APEX, the journal devoted to rapid dissemination of new findings in applied physics, will be immediately and openly accessible for anyone to read. The move reflects the increasing demand for more accessible and open science, and funders’ mandates requiring authors to publish their work in OA journals.
Making APEX open access means that authors will be ...
Art, science merge in Oregon State study of 19th-century landscape paintings’ ecological integrity
2023-09-12
CORVALLIS, Ore. – An Oregon State University-led collaboration of ecologists and art historians has demonstrated that landscape paintings from more than 150 years ago can advance environmental science.
Researchers from OSU, the U.S. Forest Service, the University of Vermont and the Smithsonian American Art Museum used 19th-century depictions of preindustrial forests in the northeastern United States to show that historical artwork can reveal information about forests and other landscapes from eras that predate modern scientific investigation.
The ...
UCLA research suggests that heart transplantation is safer for adults with single-ventricle CHD than previously thought
2023-09-12
FINDINGS
UCLA-led research finds that among adult congenital heart disease (CHD) transplant recipients, single-ventricle physiology correlated with higher short-term mortality. But 10-year conditional survival was similar for biventricular and most single-ventricle CHD patients, and notably better for biventricular CHD patients compared to non-CHD heart transplant recipients.
BACKGROUND
Congenital heart disease (CHD) is a heterogeneous group of structural abnormalities that can be thought of as spectrum from very severe ...
Turmeric may be as good for treating indigestion as drug to curb excess stomach acid
2023-09-12
A natural compound found in the culinary spice turmeric may be as effective as omeprazole—a drug used to curb excess stomach acid—for treating indigestion symptoms, suggests the first study of its kind, published online in the journal BMJ Evidence-Based Medicine.
Turmeric is derived from the root of the Curcuma longa plant. It contains a naturally active compound called curcumin thought to have anti-inflammatory and antimicrobial properties, and has long been used as a medicinal remedy, including ...